MagicTouch AVF Designed with Nanolute technology is intended for stenotic lesions of dysfunctional arteriovenous fistula and graft. 

MagicTouch AVF (Sirolimus Drug-Coated Balloon) Indicated for the treatment of stenotic lesions of dysfunctional arteriovenous fistula and graft.
01

Touch to Treat with Hemodialysis Access

Designed for patients requiring dialysis access, specifically addressing stenotic lesions in AV grafts & dysfunctional fistulas by emphasizing on prevention of recurrent intervention & higher patency.

  • Only US FDA SCB with IDE approval for AVF indication
  • The most clinically studied SCB
  • CE Approved

02

Key Indications:
  • Stenotic Lesions in dialysis patients especially 
  • Thrombosed Graft

03

Technology

Nanolute is an advanced drug delivery technology designed to enhance the efficiency of drug administration and retention, enabling sustained delivery from non-implantable devices. Nanolute is capable of delivering drugs effectively, regardless of whether their lipophilicity is poor or high.

Nanolute - Sirolimus Coated Balloon- MagicTouch PTA

Unique coating technology

Magic Touch is developed with Nanolute Technology which possesses unique circumferential coating technology that facilitates homogeneous drug distribution to target lesions

COATING
Circumferential Coating is
performed under Low Pressure inflation
leading to 100% surface area coating

REFOLDING
3 & 6 Folds

INFLATION
Homogeneous Drug Delivery
due to Circumferential Coating

04
Assuring Safety by delivering Sirolimus

TECHNOLOGY
An innovative proprietary Nanolute technology providing better bioavailability of SIROLIMUS

DRUG
Sirolimus: A drug with proven safety profile

COATING
Unique coating technology leads to 100% balloon surface coating

CARRIER
A biocompatible phospholipid drug carrier improving the adhesion property of Sirolimus

05

Documentation
Get in touch
to know more
BOOK A CALL
with our sales rep